2021, DOI: 10.1016/j.jneuroim.2021.577784) and Megan Carmilani, founder of the nonprofit Long Covid Families, described how low-dose naltrexone, or LDN, had helped her
The American Diabetes Association Standards of Care emphasizes the importance of monitoring both efficacy and tolerability of GLP-1 therapies, with follow-up frequency individualized based on the specific medication, titration schedule, and patient response
A Video Clip below on the barriers of a woman scientist to push Novo Nordisk to develop GLP-1 for obesity
FXR signaling in liver and intestinal macrophages reduces inflammation by blocking NF-B pathways and preventing the activation of IL-1, TNF-a, NLPR3 inflammasome, and caspase 1 (Fiorucci et al., 2018)